Author： Nagakawa O. Furuya Y. Fujiuchi Y. Fuse H.
Publisher： Elsevier
ISSN： 0090-4295
Source： Urology, Vol.60, Iss.3, 2002-09, pp. : 527-530
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Serum pro-gastrin-releasing peptide (31-98) in prostatic diseases
By Yashi M. Ishikawa S. Tokue A.
Urology, Vol. 62, Iss. 1, 2003-07 ,pp. :
Access to resources
Recommend
Nocturia and benign prostatic hyperplasia
By Yoshimura K. Ohara H. Ichioka K. Terada N. Matsui Y. Terai A. Arai Y.
Urology, Vol. 61, Iss. 4, 2003-04 ,pp. :
By Veltri R.W. Miller M.C. Zhao G. Ng A. Marley G.M. Wright G.L. Vessella R.L. Ralph D.
Urology, Vol. 53, Iss. 1, 1999-01 ,pp. :
Treatment of men with minimally symptomatic benign prostatic hyperplasia-PRO: the argument in favor
By Marks L.S.
Urology, Vol. 62, Iss. 5, 2003-11 ,pp. :